LLETZ (Large Loop Excision of the Transformation Zone) Fragmentation: Impact on Margin Assessment and Cervical Biopsy-LLETZ Correlation

Similar documents
EFC and European Standards for Colposcopic Evaluation

The routine use of ZedScan within one colposcopy service in England. MC Macdonald, R Lyon, JE Palmer, JA Tidy

Management of Abnormal Cervical Cytology and Histology

Understanding Your Pap Test Results

What is being excised and why? Professor Henry Kitchener Institute of Cancer Sciences The University of Manchester

Cuid d Fheidhmeannacht na Seirbhíse Sláinte. Part of the Health Service Executive. CS/PR/PM-20 Rev 2 ISBN Programme Report 2014/2015

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines

Cervical Dysplasia and HPV

Efficacy of cervical intrarepithelial neoplasia (CIN)

Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches.

Over-diagnoses in Cytopathology: Is histology the gold standard?

Colposcopy. Attila L Major, MD, PhD

Cervicovaginal Cytology: Normal and Abnormal Cells and Adequacy of Specimens

Cryotherapy has No Place in Colposcopy Practice

How invasive cervical cancer audit affects clinical practice

Woo Dae Kang, Ho Sun Choi, Seok Mo Kim

Becoming a colposcopist: Colposcope case studies

Management Algorithms for Abnormal Cervical Cytology and Colposcopy

Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary

The implications of HPV immunisation on cervical screening

!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$

The society for lower genital tract disorders since 1964.

Gynaecological surgery. Introduction. MJ Camargo, a FB Russomano, a MA Trist~ao, a G Huf, b W Prendiville c

Chapter 10: Pap Test Results

Molecular markers for diagnosis and prognosis in cervical neoplasia Eijsink, Jasper Johannes Hendrikus

QA and Quality Indicators for Cervical Cancer Screening Programs. Guglielmo Ronco MD Senior Epidemiologist CPO Piemonte Turin, Italy

CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN)

An audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia

Video Workshop Cervical cancer screening as a multidisciplinary process

BC Cancer Cervix Screening 2015 Program Results. February 2018

Histopathology: Cervical HPV and neoplasia

Diagnostic value of VIA comparing with conventional pap smear in the detection of colposcopic biopsy proved CIN

Effect of margin status on cervical intraepithelial neoplasia recurrence following LLETZ in women over 50 years

Acceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index

Management that provides continuity of care for women

ASCCP 2013 Guidelines for Managing Abnormal Cervical Cancer Screening Tests

HPV and Cervical Cancer, Screening and Prevention. John Ragsdale, MD July 12, 2018 CME Lecture Series

6 th EFC Satellite meeting, Saturday 1 st December 2018

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two

Partha Basu M.D. Screening Group/ Early Detection & Prevention Section

Completeness of excision and follow up cytology in patients treated with loop excision biopsy

Biomed Environ Sci, 2015; 28(1): 80-84

EU guidelines for reporting gynaecological cytology

cle Modern management of abnormal cervical smear Tint Tint Wai and Dilip Patil BJMP 2008:1(2) 18-22

Making Sense of Cervical Cancer Screening

Original Article Three-step approach versus see-and-treat approach in patients with cytological abnormalities

Running head: EVIDENCE-BASED MEDICINE TWO-STEP DISCREPANCY

JMSCR Vol 05 Issue 11 Page November 2017

New Diagnoses Need New Approaches: A Glimpse into the Near Future of Gynecologic Pathology

Dysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN.

Cytology Report Format

Scottish Cervical Screening Programme. Colposcopy and Programme Management

Study Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable:

A clinical review of borderline glandular cells reported on liquid-based cervical cytology

Primary High Risk HPV Testing with Cytology Triage

Risk of invasive cancer after colposcopy with and without biopsy

The LAST Guidelines in Clinical Practice. Implementing Recommendations for p16 Use

Name of External Assessment Group (EAG) and project leads

Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test(review)

Northern Ireland cervical screening programme. Information for primary care and smear takers

Cervical Conization. 1

GLANDULAR LESIONS PITFALLS IN MANAGEMENT. Dr Li Wai Hon HKSCCP The 15 th Anniversary Symposium 10 December 2016

Prof. Silvio Tatti MD, MSc, Phd, FACOG Past President IFCPC Hospital de Clínicas José de San Martín University of Buenos Aires

The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial

European Union survey on organization and quality control of cervical cancer screening and HPV vaccination programs

What is a Pap smear?

HKCOG GUIDELINES NUMBER 3 (revised November 2002) published by The Hong Kong College of Obstetricians and Gynaecologists

Article ID: WMC

ABSTRACT 1. INTRODUCTION. Tajossadat Allameh 1, Somayeh Khanjani 2, Fereshteh Mohammadizadeh 3*, Elaheh Refaei 4. sions.

GUIDELINE FOR SCREENING FOR CERVICAL CANCER: REVISED

CPC on Cervical Pathology

LABORATORY - PELVIC EXAM STUDIES COLPOSCOPY RESULTS FORM L14

UNIVERSITY OF CALGARY. Comparison of colposcopic impression, cervical punch biopsy histopathology, and final

News. Laboratory NEW GUIDELINES DEMONSTRATE GREATER ROLE FOR HPV TESTING IN CERVICAL CANCER SCREENING TIMOTHY UPHOFF, PHD, DABMG, MLS (ASCP) CM

Since the 1960s, colposcopy of the cervix with

Updated ASCCP Consensus Guidelines For Managing Diagnosed Cervical Cancer Precursors Michael A. Gold, M.D.

Treatment of Cervical Intraepithelial Neoplasia. Case. How would you manage this woman?

POST-CONIZATION FOLLOW-UP OF PATIENTS WITH HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION TREATED BY LEEP PROCEDURE: A LITERATURE REVIEW

Cervical Screening Results Leading to Detection of Adenocarcinoma in Situ of the Uterine Cervix

Quantitative Optical Spectroscopy of the Uterine Cervix: A cost effective way to detect and manage cervical disease

A comparative study of two methods of large loop excision of the transformation zone

PREVENTION OF CERVICAL CANCER

Cytology Update M Laing QEUH

ZedScan delivers improvements in clinical performance and more efficient patient management at Sheffield Teaching Hospitals NHS Foundation Trust

Abnormal Spectroscopy Scans May Presage Persistent or Progressive Cervical Dysplasia

HCT Medical Policy. High-Resolution Anoscopy for Evaluation of Anal Lesions Policy # HCT109 Current Effective Date: 10/30/2014.

Cervical Screening for Dysplasia and Cancer in Patients with HIV

Comparison between Pap smear and visual inspection with acetic acid in screening of premalignant cervical intraepithelial lesion and

I have no financial interests in any product I will discuss today.

ORIGINAL ARTICLES. Utilisation and outcomes of cervical cancer prevention services among HIV-infected women in Cape Town. Methods

Cervical Cancer Prevention in the 21 st Century Changing Paradigms

Frequency Of Nondiagnostic Findings On Colposcopy: Implications For Management

Patients referred to a colposcopy clinic will often have

A clinical review of borderline glandular cells on cervical cytology

Case Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure

ZedScan delivers improvements in clinical performance and more efficient patient management at Sheffield Teaching Hospitals NHS Foundation Trust

To ensure pleasant and comfortable surroundings during screening. If you require further treatment, we aim:

Diagnostic Value of VIA Comparing with Conventional Pap Smear in the Detection of Colposcopic Biopsy Proved CIN

Human Papillomaviruses and Cancer: Questions and Answers. Key Points. 1. What are human papillomaviruses, and how are they transmitted?

Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013

Transcription:

LLETZ (Large Loop Excision of the Transformation Zone) Fragmentation: Impact on Margin Assessment and Cervical Biopsy-LLETZ Correlation Bridget Melley BSc. (Hons.) in Medical Science Galway-Mayo Institute of Technology

Cervical Cancer 306 new cases and 93 deaths annually in Ireland (NCRI 2015) Cervical screening effective in early detection (Arbyn et al 2010) Cervical cytology and Papanicolaou staining (Arbyn et al 2010) Originates in epithelial cells of transformation zone (Cervical Check 2013)

Figure 1 Illustration of the opening to the cervix demonstrating the locations of the transformation zone, endocervix and ectocervix (adapted from dreamstime 2016).

Abnormalities associated with increased risk of progression to invasive malignancy termed Cervical Intraepithelial Neoplasia (Buckley et al 1982) CIN1, CIN2 and CIN3 Bethesda System Atypical Squamous Cells (ASC) Low Grade Squamous Intraepithelial Lesions (LSIL) High Grade Squamous Intraepithelial Lesions (HSIL)

Figure 2 Progression of cervical cancer from normal cervical epithelial cells to invasive carcinoma(adapted from Ortoski, R. A. and Kell, C. S. 2011).

What Happens After Screening? Colposcopy A magnified visual examination aided by application on contrast solutions (Stoler et al 2011) Acetowhite staining Histopathology samples abnormal tissue in order to obtain diagnosis Punch biopsy Large Loop Excision of the Transformation Zone (LLETZ) aims to excise abnormal lesion (European Commission 2008)

Figure 3 Image of intact LLETZ specimen in the Histopathology Department of Letterkenny University Hospital (longer demarcations represent centimetres).

Limitations of LLETZ Fragmentation Diathermy artefact (Bharathan et al 2013) Multiple guidelines developed to control quality of screening programme National Health Service Cervical Screening Programme (NHSCSP) Guideline Recommends removal of 80% of excisional specimens in a single fragment.

Evidence required to support guideline Associations between LLETZ fragmentation and; Indeterminate margins Margin involvement Endocervical margin involvement (Bharathan et al 2013 and Papoutsis et al 2016) Cytology Histopathology correlation used as a measure of quality (European Commission 2008)

Aims and Objectives To determine whether the NHSCSP recommendation for removal of LLETZ in a single piece is supported by scientific evidence. To investigate relationships between; LLETZ fragmentation and margin assessment LLETZ fragmentation and cervical biopsy-lletz agreement Patient age and LLETZ fragmentation Acetowhite grade and grade of subsequent cervical biopsy

Methodology Sample Selection N= 416 Cervical Sampling Prior to study Data Collection CoPath LIS Ethical approval sought and obtained from LUH ethics committee Statistical Analysis Excel, Casio fx- 85GT, Analyse-It software Data Analysis Microsoft Excel

Age Range: 20-60 years Results Mean age: 32.3 years Final Diagnosis: Negative in 15 (3.6%) CIN1 in 54 (13%) CIN2 in 187 (44.9%) CIN3 in 160 (38.5%)

LLETZ Fragmentation and Margin Interpretation 43.7% removed intact and 56.3% removed in multiple pieces Single fragment 97% margin interpretability Multiple Fragment 73.4%

Chi-Square Test: p-value < 0.0001 Rejection null hypothesis 7 outliers identified and excluded (N=373) Correlation co-efficient (r) = -0.95

Causes of Indeterminate Margins 62 reports gave reason for indeterminate margins 56 (90.3%) fragmentation 5 (8.1%) artefact 1 (1.6%) poor orientation

Patient Age and LLETZ Fragmentation Correlation co-efficient (r) = 0.00 No statistically significant relationship observed

LLETZ Fragmentation and Margin Involvement fragments margin involvement # LLETZ Fragments fragments endocervical involvement Table 1 The Percentage of LLETZ specimens with margin involvement when the LLETZ is removed in 1, 2 or 3 fragments and the proportion of involved margins which are endocervical, ectocervical, both endocervical and ectocervical or unnamed (but true) margins (N=318) % Margin Involvement % Endocervical % Ectocervical % Both % Unnamed 1 40.4 40 46.2 9.2 4.6 2 44.1 53.3 28.9 17.8 0 3 52.7 55.2 37.9 6.9 0

Agreement between Punch Biopsy and LLETZ 44.5% single piece and 55.5% multiple piece fragments kappa score 3 or more fragments perfect agreement 3 or more fragments slightly practical agreement Table 2 Summary of the perfect agreement, the practical agreement and the calculated kappa score for each group of punch biopsy and LLETZ biopsy grades when the LLETZ biopsies were removed in 1, 2 or 3 fragments (N=416) Group 1 Fragment 2 Fragment 3 Fragments Perfect Agreement 61.1% 63.7% 51.8% Practical Agreement 95.1% 95.2% 92.9% Kappa Score 0.38 0.33 0.23

Acetowhite and Punch Biopsy Grade Agreement Perfect agreement = 43.5% (163/375) Low kappa value of 0.13 Positive predictive value (PPV) = 93% Table 3 The acetowhite grade, available for 375 patients, and the grade of the corresponding and subsequent cervical punch biopsy (N=375) Acetowhite Grade Biopsy Negative Grade 1 Grade 2 Grade 3 Total Negative 8 (14%) 2 (1.9%) 2 (1.2%) 1 (2.2%) 13 CIN1 12 (21.1%) 7 (6.7%) 10 (5.9%) 2 (4.4%) 31 CIN2 30 (52.6%) 82 (78.9%) 119 (70.4%) 13 (28.9%) 244 CIN3 7 (12.3%) 13 (12.5%) 38 (22.5%) 29 (64.5%) 87 Total 57 (100%) 104 (100%) 169 (100%) 45 (100%) 375

To summarise study findings Correct sample chosen for investigation Selection criteria introduced a bias Rate of intact LLETZ (43.7%) lower than recommended 80% Increased LLETZ fragments Decreased interpretable margins Agreement with other studies Fragmentation is the primary cause of indeterminate margins

No relationship between age and LLETZ fragmentation Relationship between LLETZ fragmentation and increased endocervical margin involvement Clinically significant Decreased punch biopsy LLETZ agreement with increased fragments Not statistically significant Acetowhite is suitable for confirming presence of CIN and guiding biopsy Not suitable as predictor of histopathological grade

Limitations and Further Study Absence of data regarding colposcopist Size of sample subgroups Should be larger and relatively equal in size 1 st prize in Allied Health, in the 6 th Annual Multidisciplinary Research Sympsium in Letterkenny University Hospital

Conclusion NHSCSP guideline supported Increased LLETZ fragments; negatively impacts margin interpretation Increases likelihood of endocervical involvement Patient age does not induce LLETZ fragmentation Specific acetowhite grades are not clinically useful

Sources of Reference Arbyn, M., Anttila, A., Jordon, J., Ronco, G., Schenck, U., Segnan, N., Wiener, H., Herbert, A., and von Karsa, L. (2010) European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition Summary Document. Annals of Oncology, 21 (3), pp.448-458. Bharathan, R., Sagoo, B., Subramaniam, A., Larsen-Disney, P. And Fish, A. (2013) LLETZ Specimen Fragmentation: Impact on Diagnosis, Outcome, and Implications for Training, The Journal of Obstetrics and Gynaecology of India, 63 (5), pp.332-336. Buckley, C. H., Butler, E. B. and Fox, H. (1982) Cervical Intraepithelial Neoplasia, Journal of Clinical Pathology, Volume 35, pp.1-13. Cervical Check (2013) Guidelines for Quality Assurance in Cervical Screening Second Edition, NCSS/PUB/Q-1 Rev 2, Limerick: National Screening Service. Cervical Check (2015) Programme Report 2013-2014, CS/PR/PM-19 Rev 1, Limerick: National Cancer Screening Service. Dreamstime (2016) Transformation zone of cervix [online], available: http://www.dreamstime.com/stock-illustrationtransformation-zone-cervix-overview female-reproductive-organs-detail-image41147460 [accessed 8 May 2016]. European Commission (2008) European Guidelines for Quality Assurance in Cervical Cancer Screening Second Edition, Luxembourg: Office for Official Publications of the European Communities. National Cancer Registry Ireland (2016) Incidence Statistics [online] available: http://ncri.ie/data/incidence-statistics [accessed 10 March 2016]. Ortoski, R. A. and Kell, C. S. (2011) Anal Cancer and Screening Guidelines for Human Papillomavirus in Men, The Journal of the American Osteopathic Association, 11, pp. S35-S43. Papoutsis, D., Panikkar, J., Gornall, A. and Blundell, S. (2016) Does the number of tissue fragments removed from the cervix with excisional treatment for CIN pathology affect the completeness of excision and cytology recurrence at follow-up? An observational cohort study, Journal of Obstetrics and Gynaecology, 36, pp.251-256. Public Health England (2016) NHS Cervical Screening Programme Colposcopy and Programme Management, NHSCSP publication number 20, London: Public Health England. Stoler, M. H., Vichin, M. D., Ferenczy, A., Ferris, D. G., Gonzalo, P., Paavonen, J., Joura, E. A., Djursing, H., Sigurdsson, K., Jefferson, L., Alvarez, F., Sings, H. L., Lu, S., James, M. K., Saah, A. and Haupt, R. M. (2011) The accuracy of colposcopic biopsy: analyses from the placebo arm of the Gardasil clinical trials, International Journal of Cancer, 128, pp.1354-1362.

Thank you for listening